BIIB (Biogen Corp) Projected Sales Volume
Biogen Inc. (BIIB) maintains pricing power through patents on therapies for rare pathologies. High-cost temperature-controlled transportation ensures drug safety. Regulatory requirements restrict patient access to treatment. The projected sales volume dynamics demonstrate the fundamental maturity of the business, while the 69.66 mark serves as a key metric for assessing future revenue.
Analytical breakdowns and data insights for company Biogen Inc (BIIB)
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
BIIB - Company Net Income|Expected Profit Biogen Inc.|BIIB - Price to Earnings Multiple|Forward P/E Multiple Biogen|BIIB - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Biogen Inc|BIIB - Operating profit EBITDA|Earnings per share for the last twelve months Biogen|BIIB - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months biogen.com|BIIB - Earnings per share growth rate in current year|Earnings growth forecast for next year Biogen Inc.
- sales revenue and business income indicators:
General company analysis:Biogen Inc.
Specializing in innovative biologics for the therapy of neurodegenerative diseases in the US and Europe, Biogen Inc. (BIIB) demonstrates its commercial resilience through the company's planned sales targets. This metric compares the asset's market value with projected revenue, revealing the gap between market expectations and management's actual financial goals, which allows investors to timely identify overvaluation or hidden growth potential.
Main competitors
Company Future Sales Volume NBIX (Neurocrine Biosciences)|RGC (regencellbioscience.com) - Company Future Revenue|Projected Sales Volume AXSM (Axsome Therapeutics, Inc.)|Company Future Sales ACADIA Pharma (ACAD)|XENE - Company Projected Revenue|VKTX (Viking Therapeutics Corp) - Company Revenue Forecast|SUPN: Projected Sales Volume|Company Future Sales Volume catalystpharma.com|Company Future Sales Volume DNLI|Harmony Biosciences Inc (HRMY) - Company Future Sales|Projected Sales Volume BHVN|Company Projected Revenue AMLX (Amylyx Corp)|Projected Sales Volume TRVI (Trevi Therapeutics)|Company Future Sales praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Projected Sales Volume|Company Future Sales CeriBell Inc CBLL|PRTA: Projected Sales Volume|ALEC (Alector) - Company Projected Revenue|Company Projected Revenue Annexon, Inc.|Company Revenue Forecast OMER (Omeros Corp.)|Projected Sales Volume NGNE|ACIU - Company Expected Sales Volume|Voyager Pharma - Company Future Sales Volume|Projected Sales Volume Neumora Corp NMRA|SCLX - Company Projected Revenue|Company Future Revenue TVGN (tevogen.com)|alphacognition.com (ACOG) - Company Projected Revenue|Company Expected Sales Volume cogrx.com (CGTX)|IKT (Inhibikase) - Projected Sales Volume|Company Projected Revenue SAVA|Projected Sales Volume ASRT|Company Future Sales coyatherapeutics.com|Company Projected Revenue Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Company Expected Sales Volume|Acumen Pharma - Projected Sales Volume|Company Sales Forecast CervoMed Corporation (CRVO)|ATHE: Projected Sales Volume|Company Expected Sales Volume Clene (CLNN)|Company Projected Revenue PepGen Inc|Company Revenue Forecast JUNS (jupiterneurosciences.com)|Company Future Sales Volume RLMD (Relmada)|ANVS (Annovis Bio Corporation) - Company Future Revenue|Projected Sales Volume GRCE (Grace Therapeutics)|Company Future Sales fireflyneuro.com (AIFF)|KLTO - Company Projected Revenue|NRSN (NeuroSense Therapeutics) - Company Revenue Forecast|RVPH: Projected Sales Volume|Company Future Sales Volume MetaVia|Company Future Sales Volume NRXS|Helius Medical Technologies Inc. (HSDT) - Company Future Sales|Projected Sales Volume PASG|Company Projected Revenue NEUP (bionomics.com.au)|Projected Sales Volume NERV (Minerva Neurosciences Corp)|Company Future Sales Athira Pharma Corp (ATHA)|Addex Therapeutics - Projected Sales Volume|Company Future Sales Alzamend Neuro, Inc. ALZN|CYCN: Projected Sales Volume|PTIX (Protagenic Therapeutics, Inc.) - Company Projected Revenue|Company Projected Revenue Pasithea Therapeutics Corp|Company Revenue Forecast CRGT (Cortigent Medical)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Cara Therapeutics - Company Future Sales Volume|Projected Sales Volume Chromocell Therapeutics Corp CHRO|ELYM - Company Projected Revenue|Company Future Revenue ITCI (Intra-Cellular Therapies)|Longboard Pharmaceuticals (LBPH) - Company Projected Revenue|Company Expected Sales Volume marinuspharma.com (MRNS)|NKGN (NKGen Biotech) - Projected Sales Volume|Company Projected Revenue NRBO|Projected Sales Volume SAGE|Company Future Sales Synaptogenix, Inc|Company Projected Revenue Trevena, Inc. TRVN|Vigil Neuroscience Inc. (VIGL) - Company Expected Sales Volume|Anew Medical, Inc. - Projected Sales Volume|Company Sales Forecast Cerevel Therapeutics Inc (CERE)
